Evidence map›Paper›PMID 27154267›Full record

ReviewAdvanced drug delivery reviews2016

Toxicology of graphene-based nanomaterials.

Gaurav Lalwani, Michael D'Agati, Amit Mahmud Khan, Balaji Sitharaman

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. BiACS omega · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Gaurav LalwaniTheragnostic Technologies Inc., Long Island High Technology Incubator Suite 123, Stony Brook, NY 11790, USA; Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794-5281, USA. Electronic address: gauravlalwani06@gmail.com.
Michael D'AgatiDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794-5281, USA.
Amit Mahmud KhanDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794-5281, USA.
Balaji SitharamanTheragnostic Technologies Inc., Long Island High Technology Incubator Suite 123, Stony Brook, NY 11790, USA; Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794-5281, USA. Electronic address: balaji.sitharaman@stonybrook.edu.

Funding

Nanotechnology-based Theranostic Technology for Bone Tissue EngineeringDP2OD007394 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI SITHARAMAN, BALAJI · 2010 to 2010
$2.4M
NIH HHS DP2 OD007394
6 · The paper itself

Abstract

Graphene based nanomaterials possess remarkable physiochemical properties suitable for diverse applications in electronics, telecommunications, energy and healthcare. The human and environmental exposure to graphene-based nanomaterials is increasing due to advancements in the synthesis, characterization and large-scale production of graphene and the subsequent development of graphene based biomedical and consumer products. A large number of in vitro and in vivo toxicological studies have evaluated the interactions of graphene-based nanomaterials with various living systems such as microbes, mammalian cells, and animal models. A significant number of studies have examined the short- and long-term in vivo toxicity and biodistribution of graphene synthesized by variety of methods and starting materials. A key focus of these examinations is to properly associate the biological responses with chemical and morphological properties of graphene. Several studies also report the environmental and genotoxicity response of pristine and functionalized graphene. This review summarizes these in vitro and in vivo studies and critically examines the methodologies used to perform these evaluations. Our overarching goal is to provide a comprehensive overview of the complex interplay of biological responses of graphene as a function of their physiochemical properties.

Indexed as

AnimalsAnti-Infective AgentsGraphiteHumansNanostructuresAnti-Infective AgentsGraphiteAntimicrobialBiodistributionEnvironmentalGrapheneIn vitroIn vivoToxicity

Identifiers

PMID27154267
PMCPMC5039077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.